RGEN
Repligen CorporationPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #467
- Final score
- 51.16
- Years on list
- 6
↗ Climbed 327 since 2021
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 327 since 2021
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 276 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 159 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | RGEN | GILD | AVTR |
|---|---|---|---|
| Climate Change | 61.6 | 58.2 | 62.1 |
| Employee Relations | 48.3 | 53.3 | 48.6 |
| Environment | 46.4 | 35.3 | 43.8 |
| Stakeholders & Society | 51.6 | 65.9 | 54.6 |
| Human Rights | 51.5 | 39.7 | 41.5 |
| Governance | 40.7 | 53.5 | 39.7 |
| Performance Rating | 51.6 | 60.4 | 51.7 |